Prestige Consumer Healthcare Inc. (PBH)
USD 82.12
(-0.04%)
USD 82.12
(-0.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 624.44 Million USD | -0.14% |
| 2023 | 625.29 Million USD | 0.75% |
| 2022 | 620.64 Million USD | 13.37% |
| 2021 | 547.47 Million USD | -0.86% |
| 2020 | 552.22 Million USD | -0.6% |
| 2019 | 555.57 Million USD | -3.63% |
| 2018 | 576.5 Million USD | 15.24% |
| 2017 | 500.28 Million USD | 7.08% |
| 2016 | 467.21 Million USD | 15.01% |
| 2015 | 406.22 Million USD | 19.46% |
| 2014 | 340.05 Million USD | -2.06% |
| 2013 | 347.21 Million USD | 52.7% |
| 2012 | 227.38 Million USD | 33.07% |
| 2011 | 170.87 Million USD | 8.54% |
| 2010 | 157.43 Million USD | -3.57% |
| 2009 | 163.27 Million USD | -3.11% |
| 2008 | 168.5 Million USD | 1.82% |
| 2007 | 165.48 Million USD | 5.25% |
| 2006 | 157.23 Million USD | -2.92% |
| 2005 | 161.97 Million USD | 213.63% |
| 2004 | 51.64 Million USD | 15.49% |
| 2003 | 44.71 Million USD | 62.5% |
| 2002 | 27.51 Million USD | 393.15% |
| 2001 | 5.58 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 157.93 Million USD | -1.3% |
| 2024 Q4 | 146.13 Million USD | -7.47% |
| 2024 FY | 601.89 Million USD | -3.74% |
| 2024 Q1 | 154.67 Million USD | 0.59% |
| 2024 Q2 | 160.02 Million USD | 3.46% |
| 2023 Q2 | 161 Million USD | 0.56% |
| 2023 FY | 625.29 Million USD | 0.75% |
| 2023 Q4 | 153.76 Million USD | 2.24% |
| 2023 Q3 | 150.4 Million USD | -6.59% |
| 2023 Q1 | 160.11 Million USD | 7.56% |
| 2022 Q3 | 155.06 Million USD | -1.68% |
| 2022 FY | 620.64 Million USD | 13.37% |
| 2022 Q1 | 159.01 Million USD | 16.02% |
| 2022 Q2 | 157.71 Million USD | -0.82% |
| 2022 Q4 | 148.86 Million USD | -4.0% |
| 2021 Q2 | 137.66 Million USD | 2.83% |
| 2021 Q3 | 138.88 Million USD | 0.89% |
| 2021 Q1 | 133.86 Million USD | -6.98% |
| 2021 FY | 547.47 Million USD | -0.86% |
| 2021 Q4 | 137.05 Million USD | -1.32% |
| 2020 Q2 | 136.75 Million USD | 2.0% |
| 2020 Q4 | 143.91 Million USD | 4.67% |
| 2020 FY | 552.22 Million USD | -0.6% |
| 2020 Q1 | 134.06 Million USD | -3.02% |
| 2020 Q3 | 137.49 Million USD | 0.54% |
| 2019 Q4 | 138.24 Million USD | -0.71% |
| 2019 Q3 | 139.23 Million USD | 1.28% |
| 2019 Q2 | 137.47 Million USD | -2.24% |
| 2019 Q1 | 140.62 Million USD | -0.45% |
| 2019 FY | 555.57 Million USD | -3.63% |
| 2018 Q4 | 141.25 Million USD | -4.35% |
| 2018 FY | 576.5 Million USD | 15.24% |
| 2018 Q1 | 143.47 Million USD | 10.21% |
| 2018 Q2 | 144.09 Million USD | 0.43% |
| 2018 Q3 | 147.67 Million USD | 2.48% |
| 2017 Q4 | 130.18 Million USD | 4.53% |
| 2017 FY | 500.28 Million USD | 7.08% |
| 2017 Q3 | 124.54 Million USD | 0.47% |
| 2017 Q2 | 123.96 Million USD | 1.95% |
| 2017 Q1 | 121.59 Million USD | 2.82% |
| 2016 Q2 | 119.94 Million USD | 6.86% |
| 2016 Q4 | 118.25 Million USD | 1.26% |
| 2016 Q3 | 116.78 Million USD | -2.63% |
| 2016 FY | 467.21 Million USD | 15.01% |
| 2016 Q1 | 112.23 Million USD | 1.97% |
| 2015 FY | 406.22 Million USD | 19.46% |
| 2015 Q3 | 111.74 Million USD | 8.97% |
| 2015 Q1 | 81.86 Million USD | 2.28% |
| 2015 Q2 | 102.54 Million USD | 25.26% |
| 2015 Q4 | 110.07 Million USD | -1.5% |
| 2014 Q2 | 94.71 Million USD | 13.46% |
| 2014 Q4 | 80.04 Million USD | -2.16% |
| 2014 Q3 | 81.8 Million USD | -13.63% |
| 2014 FY | 340.05 Million USD | -2.06% |
| 2014 Q1 | 83.48 Million USD | -5.21% |
| 2013 Q3 | 84.99 Million USD | -6.13% |
| 2013 FY | 347.21 Million USD | 52.7% |
| 2013 Q4 | 88.07 Million USD | 3.62% |
| 2013 Q2 | 90.54 Million USD | 8.3% |
| 2013 Q1 | 83.6 Million USD | 22.07% |
| 2012 Q4 | 68.48 Million USD | 24.25% |
| 2012 Q1 | 49.86 Million USD | 7.69% |
| 2012 Q2 | 53.9 Million USD | 8.1% |
| 2012 FY | 227.38 Million USD | 33.07% |
| 2012 Q3 | 55.12 Million USD | 2.26% |
| 2011 Q2 | 42.59 Million USD | 9.54% |
| 2011 Q1 | 38.87 Million USD | 9.63% |
| 2011 Q4 | 46.3 Million USD | 5.21% |
| 2011 Q3 | 44.01 Million USD | 3.34% |
| 2011 FY | 170.87 Million USD | 8.54% |
| 2010 Q2 | 44.33 Million USD | 14.11% |
| 2010 Q4 | 35.46 Million USD | -10.91% |
| 2010 FY | 157.43 Million USD | -3.57% |
| 2010 Q1 | 38.85 Million USD | 10.1% |
| 2010 Q3 | 39.8 Million USD | -10.21% |
| 2009 Q2 | 46.25 Million USD | 17.82% |
| 2009 Q3 | 42.46 Million USD | -8.21% |
| 2009 FY | 163.27 Million USD | -3.11% |
| 2009 Q4 | 35.28 Million USD | -16.89% |
| 2009 Q1 | 39.26 Million USD | -4.73% |
| 2008 Q4 | 41.21 Million USD | -0.55% |
| 2008 Q2 | 44.56 Million USD | 7.94% |
| 2008 Q3 | 41.43 Million USD | -7.02% |
| 2008 Q1 | 41.28 Million USD | 5.22% |
| 2008 FY | 168.5 Million USD | 1.82% |
| 2007 Q1 | 39.59 Million USD | -9.61% |
| 2007 Q2 | 43.29 Million USD | 9.33% |
| 2007 Q3 | 43.35 Million USD | 0.15% |
| 2007 Q4 | 39.23 Million USD | -9.5% |
| 2007 FY | 165.48 Million USD | 5.25% |
| 2006 Q1 | 35.21 Million USD | -21.57% |
| 2006 Q4 | 43.8 Million USD | 6.51% |
| 2006 Q2 | 37.79 Million USD | 7.33% |
| 2006 Q3 | 41.13 Million USD | 8.82% |
| 2006 FY | 157.23 Million USD | -2.92% |
| 2005 Q1 | 31.63 Million USD | 0.0% |
| 2005 Q2 | 43.5 Million USD | 37.52% |
| 2005 FY | 161.97 Million USD | 213.63% |
| 2005 Q3 | 41.93 Million USD | -3.61% |
| 2005 Q4 | 44.9 Million USD | 7.09% |
| 2004 FY | 51.64 Million USD | 15.49% |
| 2003 FY | 44.71 Million USD | 62.5% |
| 2002 FY | 27.51 Million USD | 393.15% |
| 2001 FY | 5.58 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Cardinal Health, Inc. | 7.41 Billion USD | 91.577% |
| Cencora | 9.91 Billion USD | 93.699% |
| McKesson Corporation | 12.2 Billion USD | 94.882% |
| Owens & Minor, Inc. | 2.12 Billion USD | 70.616% |